Reimbursement for drugs — a register study comparing economic outcome for five healthcare centres in areas with different socioeconomic conditions

Scandinavian Journal of Public Health

Volumn 37, Issue 6, 2009, Pages 647-653

  Semark, B ^a   Fredlund, K ^b   Astrand B ^a   Brudin, L ^c  

^a LINNAEUS UNIVERSITY   (Sweden)

^b Lindsdals Primary Health Centre   (Sweden)

^c LINKÖPING UNIVERSITY   (Sweden)

Author keywords

drug benefit; primary healthcare; Reimbursement; socioeconomic conditions

Indexed keywords

ANALGESIC AGENT; ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANXIOLYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRONCHODILATING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARDIOVASCULAR AGENT; DIURETIC AGENT; GASTROINTESTINAL AGENT; RESPIRATORY TRACT AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CHILD; COMPENSATION; DIABETES MELLITUS; DRUG COST; ECONOMIC EVALUATION; EDUCATION; HEALTH CENTER; HEALTH PROGRAM; HEALTH STATUS; HUMAN; HYPERTENSION; INCOME; INFANT; LIFESTYLE; MAJOR CLINICAL STUDY; MORBIDITY; PRIMARY HEALTH CARE; PRIORITY JOURNAL; REGISTER; REIMBURSEMENT; SOCIOECONOMICS; STOMACH DISEASE; SWEDEN; UNEMPLOYMENT;

COMMUNITY HEALTH CENTERS; DRUG COSTS; FEES, PHARMACEUTICAL; HUMANS; PHARMACEUTICAL PREPARATIONS; PRESCRIPTION DRUGS; PRIMARY HEALTH CARE; REGISTRIES; REIMBURSEMENT MECHANISMS; SOCIOECONOMIC FACTORS; SWEDEN;

EID: 68649124333     PISSN: 14034948     EISSN: None     Source Type: Journal    
DOI: 10.1177/1403494809106544     Document Type: Article

References (27)

1. Hemstrom O. Health inequalities by wage income in Sweden: the role of work environment. Soc Sci Med 2005;61:637-647.
2. Loucks E.B., Magnusson K.T., Cook S., Rehkopf D.H., Ford E.S., Berkman L.F. Socioeconomic position and the metabolic syndrome in early, middle, and late life: evidence from NHANES 1999-2002. Ann Epidemiol 2007;17:782-790.
3. Mol G.D., van de Lisdonk EH, Smits J.P., van den Hoogen JM, Bor J.H., Westert G.P. A widening health gap in general practice? Socio-economic differences in morbidity between 1975 and 2000 in The Netherlands. Public Health 2005;119:616-625.
4. Koster A., Bosma H., Kempen G.I., van Lenthe F.J., van Eijk J.T., Mackenbach J.P. Socioeconomic inequalities in mobility decline in chronic disease groups (asthma/COPD, heart disease, diabetes mellitus, low back pain): only a minor role for disease severity and comorbidity. J Epidemiol Community Health 2004;58:862-9.
5. Power C., Hypponen E., Smith G.D. Socioeconomic position in childhood and early adult life and risk of mortality: a prospective study of the mothers of the 1958 British birth cohort. Am J Public Health 2005;95:1396-1402.
6. Ess S.M., Schneeweiss S., Szucs T.D. European healthcare policies for controlling drug expenditure. Pharmacoeconomics 2003;21:89-103.
7. Schneeweiss S. Reference drug programs: effectiveness and policy implications. Health Policy 2007;81:17-28.
8. Martikainen J., Kivi I., Linnosmaa I. European prices of newly launched reimbursable pharmaceuticals - a pilot study. Health Policy 2005;74:235-246.
9. Vogler S.H.C., Leopold C., Rosian-Schikuta I., de Joncheere K., Layer Thomsen T. PPRI report. Vienna: European Commission, Directorate-General Health and Consumer Protection, Austrian Federal Ministry of Health, Family and Youth; 2008.
10. Peura S.R.S., Kurkijärvi U. Finland Pharma Profile. Vienna: European Commission, Health and Consumer Protection Directorate-General, Austrian Ministry of Health, Family and Youth; 2007.
11. Frostelid T.H.T., Sveen K., Gregersen T., Grosvold I. Norway Pharma Profile. Vienna: European Commission, Health and Consumer Protection Directorate General, Austrian Ministry of Health, Family and Youth; 2007.
12. Thomsen E.E.S., Fonnesbaek Rasmussen P. Denmark Pharma Profile. Vienna: European Commission, Health and Consumer Protection Directorate-General, Austrian Ministry of Health, Family and Youth; 2008.
13. Redman Tkhm. Sweden Pharma Profile. Vienna: European Commission, Health Consumer Protection Directorate-General, Austrian Ministry of Health, Family and Youth; 2007.
14. Basagana X., Sunyer J., Kogevinas M., Zock J.P., Duran-Tauleria E., Jarvis D., et al. Socioeconomic status and asthma prevalence in young adults: the European Community Respiratory Health Survey. Am J Epidemiol 2004;160:178-188.
15. Bayard-Burfield L., Sundquist J., Johansson S.E. Ethnicity, self reported psychiatric illness, and intake of psychotropic drugs in five ethnic groups in Sweden. J Epidemiol Community Health 2001;55:657-664.
16. Brekke M., Hjortdahl P., Kvien T.K. Severity of musculoskeletal pain: relations to socioeconomic inequality. Soc Sci Med 2002; 54:221-8.
17. de Gaudemaris R., Lang T., Chatellier G., Larabi L., Lauwers-Cances V., Maitre A., et al. Socioeconomic inequalities in hypertension prevalence and care: the IHPAF Study. Hypertension 2002;39:1119-1125.
18. Gadd M., Johansson S.E., Sundquist J., Wandell P. Morbidity in cardiovascular diseases in immigrants in Sweden. J Intern Med 2003;254:236-243.
19. Gadd M., Johansson S.E., Sundquist J., Wandell P. The trend of cardiovascular disease in immigrants in Sweden. Eur J Epidemiol 2005;20:755-760.
20. Huisman M., Kunst A.E., Bopp M., Borgan J.K., Borrell C., Costa G., et al. Educational inequalities in cause-specific mortality in middle-aged and older men and women in eight western European populations. Lancet 2005;365: 493-500.
21. Li X., Sundquist J., Sundquist K. Socioeconomic and occupational groups and risk of asthma in Sweden. Occup Med (Lond) 2008;58:161-8.
22. Sundquist J., Malmstrom M., Johansson S.E. Cardiovascular risk factors and the neighbourhood environment: a multilevel analysis. Int J Epidemiol 1999;28:841-5.
23. Sundquist K., Malmstrom M., Johansson S.E. Neighbourhood deprivation and incidence of coronary heart disease: a multilevel study of 2.6 million women and men in Sweden. J Epidemiol Community Health 2004;58:71-77.
24. Dalstra J.A., Kunst A.E., Borrell C., Breeze E., Cambois E., Costa G., et al. Socioeconomic differences in the prevalence of common chronic diseases: an overview of eight European countries. Int J Epidemiol 2005;34:316-326.
25. Nielsen M.W., Hansen E.H., Rasmussen N.K. Prescription and non-prescription medicine use in Denmark: association with socio-economic position. Eur J Clin Pharmacol 2003; 59:677-684.
26. Nielsen M.W., Hansen E.H., Rasmussen N.K. Patterns of psychotropic medicine use and related diseases across educational groups: national cross-sectional survey. Eur J Clin Pharmacol 2004;60:199-204.
27. Al-Windi A., Elmfeldt D., Svardsudd K. Determinants of drug utilisation in a Swedish municipality. Pharmacoepidemiol Drug Safety 2004;13:97-103.